People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of the price and not approved by the FDA ...

The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold to US consumers.

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

For decades, the United States has led the world in pharmaceutical innovation -- developing drugs that combat cancer, heart disease, AIDS, diabetes and other ...

We don’t think it is a coincidence that Americans have been consuming less junk food ever since the FDA approved the use of the GLP-1 drugs made by pharmaceutical giants Eli Lilly (Zepbound ) and Novo ...

And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...